Victoria Engblom/Forbes In February, Congress brought in a group of pharmaceutical CEOs and executives from seven companies to testify about the high price of prescription drugs. On Tuesday, Congress is set to keep the conversation going, this time grilling pharmacy benefit managers, the little-known middlemen responsible for negotiating drug prices. In their testimony, executives from […]